Biltzar ekarpenak (1) Ikertzaileren baten partaidetza izan duten argitalpenak

2017

  1. Randomized phase III trial of trastuzumab plus capecitabine with or without pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who experienced disease progression during or after trastuzumab-based therapy

    Journal of Clinical Oncology